Aetna policies
Search Aetna's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
Checking prior authorization for Q5129? Open Aetna’s official lists and confirm the member’s product there.
9 policies name Q5129, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0902-Irinotecan Liposome Injection (Onivyde) | 0902 · Commercial | 21 | Original policy ↗ |
| Vascular Endothelial Growth Factor Inhibitors for Ocular Indications | 0701 · Commercial | 29 | Original policy ↗ |
| 0795-Dexamethasone Ophthalmic Implant (Ozurdex) and Insert (Dextenza) | 0795 · Commercial | 31 | Original policy ↗ |
| 0685-Bevacizumab for Non-Ocular Indications | 0685 · Commercial | 33 | Original policy ↗ |
| Atezolizumab (Tecentriq) and Atezolizumab and Hyaluronidase-tqjs (Tecentriq Hybreza) | 0909 · Commercial | 46 | Original policy ↗ |
| 0111-Indocyanine Green Angiography | 0111 · Commercial | 60 | Original policy ↗ |
| 0890-Pembrolizumab Products (Keytruda and Keytruda Qlex) | 0890 · Commercial | 82 | Original policy ↗ |
| Participating provider precertification list for Aetna® | 1013000-01-35 · Effective Nov 1, 2025 · Commercial | 1,389 | Original policy ↗ |
| Participating provider precertification list for Aetna® | Effective Jan 1, 2026 · Commercial | 1,440 | Original policy ↗ |